Company Filing History:
Years Active: 2019-2020
Title: Lance Hellman: Innovator in Molecular Constructs and Protein Folding
Introduction
Lance Hellman is a notable inventor based in Granger, IN (US). He has made significant contributions to the fields of molecular constructs and protein folding, holding a total of 2 patents. His work focuses on enhancing the specificity and affinity of T-cell receptors, as well as improving the efficiency of protein production.
Latest Patents
Hellman's latest patents include groundbreaking innovations in molecular constructs and their applications. One patent details molecular constructs and dual recognition constructs that encode a TCR affinity weakening motif. These constructs allow modified T-cells to express a modified TCR, which reduces non-specific binding while enhancing binding specificity and affinity for target antigens. This advancement is crucial for the treatment of cancer and T-cell mediated pathologies. Another patent presents a microscale method for producing correctly folded and biologically active proteins in a significantly shorter time frame compared to traditional techniques. This method allows for high-throughput production of complex proteins, which is essential for epitope discovery protocols.
Career Highlights
Throughout his career, Lance Hellman has worked with prestigious institutions such as the University of Notre Dame Du Lac and the University of Massachusetts. His research has led to significant advancements in the understanding and application of modified T-cells and protein folding techniques.
Collaborations
Some of his notable coworkers include Brian M. Baker and Brian Gregory Pierce. Their collaborative efforts have contributed to the success of Hellman's innovative projects.
Conclusion
Lance Hellman's work in molecular constructs and protein folding represents a significant advancement in biomedical research. His patents reflect a commitment to improving therapeutic strategies for cancer and other diseases. His contributions continue to influence the field and pave the way for future innovations.